BIVI
BioVie Inc.NASDAQHealthcare$1.42+3.52%ClosedMarket Cap: $10.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.60
P/S
0.00
EV/EBITDA
0.52
DCF Value
$12.83
FCF Yield
-129.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-82.0%
ROA
-77.5%
ROIC
-92.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $0.00 | -Infinity% | $-6.3M | $-6.1M | $-0.77 | — |
| Q1 2026 | $0.00 | -Infinity% | $-5.3M | $-5.1M | $-0.98 | — |
| Q4 2025 | $0.00 | -Infinity% | $-3.7M | $-3.5M | $-1.82 | — |
| FY 2025 | $0.00 | -Infinity% | $-18.1M | $-17.5M | $-12.12 | — |
| Q3 2025 | $0.00 | NaN% | $-3.0M | $-2.8M | $-1.50 | — |
| Q2 2025 | $0.00 | NaN% | $-7.3M | $-7.1M | $-4.60 | — |
| Q1 2025 | $0.00 | NaN% | $-4.1M | $-4.2M | $-7.00 | — |
| Q4 2024 | $0.00 | -Infinity% | $-4.8M | $-4.9M | $-8.30 | — |
| FY 2024 | $0.00 | NaN% | $-32.2M | $-32.1M | $-73.05 | — |
| Q3 2024 | $0.00 | NaN% | $-7.7M | $-8.1M | $-20.00 | — |
| Q2 2024 | $0.00 | NaN% | $-8.8M | $-8.4M | $-2.20 | — |
| Q1 2024 | $0.00 | NaN% | $-10.9M | $-10.7M | $-2.92 | — |